Approach to elucidate effect of ketamine on treatment resistant depression

Approach to elucidate effect of ketamine on treatment resistant depression - ketamine and depression

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034922

Enrollment

Registered

2019-01-01

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

administration of ketamine ( 0.5mg/kg ) for 40 min every 7 days for 2 week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: treatment resistant depression

Exclusion criteria

Exclusion criteria: patients whom the psychiatrist diagnose inappropriate

Design outcomes

Primary

Measure	Time frame
antidepressant effect measurement of ketamine	—

Countries

Japan

Contacts

Public ContactTakash Kudo

Hirosaki University Hospital department of anesthesiology

takf5@hirosaki-u.ac.jp+81172335111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026